Clinical Trial Update: Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS [Phase 3]

View source ↗

Summary

The Phase 3 trial of pridopidine for amyotrophic lateral sclerosis is currently recruiting, with the study designed to evaluate its efficacy and safety in ALS. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Pridopidine (pridopidine)

Snippet

Sponsor: Prilenia | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: RECRUITING